Search Results for: us stem cell

Woman’s death after “no big deal” fat stem cell therapy: coroner investigating

/ / 20 Comments
Macquarie-Stem-Cells

An elderly woman in Australia reportedly died shortly after receiving a fat stem cell transplant. Sheila Drysdale passed away hours after getting an adipose stem cell treatment a few days before Christmas in 2013. That death is now being investigated by the coroner there. Not only is this death in Sydney distressing in it of […]

Woman’s death after “no big deal” fat stem cell therapy: coroner investigating Read More »

Stem cell biotech bites: Mesoblast, BioTime, MS, FDA Warning, & More

/ / 4 Comments
Mesoblast-stock

Stem cell studies continue to make big news with a mixed bag of trends including for stem cell biotech, and some good stem cell news and others not so much. Mesoblast ($MESO) had its stock suspended for quite so time recently in anticipation of a big announcement. When that news came today it was discouraging in

Stem cell biotech bites: Mesoblast, BioTime, MS, FDA Warning, & More Read More »

Weekend reads: ES cell research polls well, Gordie Howe, MS, IPS cells, and more

/ / 1 Comment
Gallup-Poll-stem-cells

Here are some headlines & articles worth a look and some thought on stem cell and biomedical science more generally. Gallup finds in a new poll that 60% of Americans surveyed find human embryonic stem celsl research “largely acceptable”. On the other hand human reproductive cloning is highly frowned upon, sandwiched in the “highly unacceptable

Weekend reads: ES cell research polls well, Gordie Howe, MS, IPS cells, and more Read More »

Good stem cell news as Masayo Takahashi IPS Cell Trial to Resume

/ / 9 Comments
Masayo-Takahashi

Some good news today as the pioneering induced pluripotent stem (IPS) cell trial led by Dr. Masayo Takahashi will resume. This clinical study with a focus on macular degeneration has been on hold for quite some time due to regulatory changes in Japan. There had also been concerns over mutations in the 2nd patient’s IPS

Good stem cell news as Masayo Takahashi IPS Cell Trial to Resume Read More »

Stem cells for stroke hype analysis: 9 very different headlines

/ / 16 Comments
stem-cells-stroke-hype-e1465060807608

I wrote yesterday about two cases of science media hype on CRISPR and on stem cells for strokes. The latter case on stem cell hype stirred the most discussion and even some harsh words in the comments. As this stem cell stroke story on an encouraging but very small, preliminary study has unfolded across the

Stem cells for stroke hype analysis: 9 very different headlines Read More »

2 Recent Science Hype Awards on CRISPR & Stem Cells

/ / 12 Comments
Stem-cell-hype

Science hype deserves negative attention for the harm it does including both to science itself and to patients. I’ve seen two really egregious examples of hype lately in science headlines. First from the Washington Post comes a stem cell story with a very hype-ful title: Stanford researchers ‘stunned’ by stem cell experiment that helped stroke

2 Recent Science Hype Awards on CRISPR & Stem Cells Read More »

Ten patient groups oppose REGROW Act that would gut stem cell oversight

/ / 9 Comments
michael-j.-fox-foundation

The REGROW Act would drastically weaken FDA regulation of experimental stem cell therapies. I’ve criticized it in numerous posts (see those here) for its radical ideas that would put patients and the stem cell field at risk. I’m not the only one concerned about it as both ARM and ISSCR oppose it too. Now 10 top patient advocacy

Ten patient groups oppose REGROW Act that would gut stem cell oversight Read More »

End of line for StemCells Inc., pioneering & controversial stem cell biotech

/ / 10 Comments
stemcellsinc-logo

A sad, but not surprising day for the stem cell field as the biotech StemCells, Inc. announced that it is winding down its operations after terminating its spinal cord injury trial called the Pathway Study. The data generated so far did not justify continuing the trial. StemCells, Inc. (stock symbol STEM) has struggled financially for

End of line for StemCells Inc., pioneering & controversial stem cell biotech Read More »

Haruko Obokata (小保方 晴子) website posts dubious STAP cell validation data

/ / 3 Comments
STAP-cell-Obokata-2016

Haruko Obokata is most well-known for her role as first author of the now retracted two STAP cell Nature papers. These manuscripts claimed to have made pluripotent and even totipotent stem cells simply by stressing cells out with acid treatment or in other ways. Nobody else could get this method to work to create the so-called

Haruko Obokata (小保方 晴子) website posts dubious STAP cell validation data Read More »